Skip to main content

Table 3 Disposition, length of stay, and antibiotic treatment details for ABSSSI treatment in the ED, hospital, and upon discharge

From: Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

Disposition or Antibiotic Details ED
(n = 94)
Hospital
(n = 69)
Upon Discharge (n = 94)
From ED
(n = 25)
From hospital (n = 69)
Disposition
 Home 25 (26.6) 60 (87.0)
 Admit to Hospital 69 (73.4)  
 Skilled nursing facility 9 (13.0)
LOS (hours or days), median (25th, 75th percentile) 7.1 (4.6, 15.0) 4 (2, 7)
Antibiotics prescribed to patient
 None 7 (7.4) 1 (1.4) 11 (15.9)
 Beta-lactams 48 (51.1) 52 (75.4) 15 (60) 36 (62.1)
 TMP/SMZ 12 (12.8) 4 (5.8) 12 (48) 5 (8.6)
 Tetracyclines 2 (2.1) 3 (4.3) 4 (16) 11 (19)
 Vancomycin 49 (52.1) 54 (78.3) 5 (8.6)
 Clindamycin 17 (18.1) 9 (13.0) 6 (24) 4 (6.9)
 Fluoroquinolones 1 (1.1) 2 (2.9) 5 (8.6)
 Daptomycin 3 (4.3) 2 (3.4)
 Linezolid 2 (2.9) 2 (3.4)
 Metronidazole 4 (5.8) 2 (3.4)
LOT (days), median (25th, 75th percentile) 2 (2, 4) 7 (7, 10) 10 (7, 14)
Route of administration
 IV 74 (85.1) 51 (75.8) 1 (4) 13 (22.4)
 IV plus Oral 9 (10.3) 16 (23.5) 1 (1.7)
 Oral 4 (4.6) 1 (1.5) 24 (96) 44 (75.9)
  1. LOS length of stay (hours for ED column, days for hospital column), TMP/SMZ, trimethoprim/sulfamethoxazole, LOT, length of treatment, IV intravenous